Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

biotech

Top Biotechs Set to Win in the War on Cancer

Tuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key data from several of the companies covered by the biotech ...
Read Full Story »
Merger

Could Questcor and Under Armour Be the Next Big Buyout Stocks?

Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) and Under Armour Inc. (NYSE: UA) may seem to have little to nothing in common on the surface. Questcor is in the pharmaceutical business, while ...
Read Full Story »
Stock Split Image

Will Attorney Investigations or Class Action Suits Put Amgen-Onyx Buyout at Risk?

Any time you see a merger announcement, you see a myriad of press releases pertaining to law firms and lawyers investigating the terms of the deal. This is in one ...
Read Full Story »
Merger

Lessons of Buying Growth Companies Doubling Their Revenues

Amgen Inc. (NASDAQ: AMGN) wants to regain its status as the largest publicly traded biotech in the U.S. The company formalized a buyout of cancer drug maker Onyx Pharmaceuticals Inc. (NASDAQ: ...
Read Full Story »
95992888

Ten Companies Expected to Double Revenues in the Next Few Years

If you have analyzed the myriad earnings reports over the summer of 2013, the trend that you will notice is a lack of revenue growth from most major companies. Many ...
Read Full Story »
Bull and Bear

Top 10 Analyst Upgrades and Downgrades: FedEx, Onyx, 3D Systems, YRC and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Crocs, GE, Nokia and More

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall ...
Read Full Story »
95992888

Ten Top Large Cap Stocks to Buy With the Most Upside Potential

When we screen stocks at the Wall Street firms we cover, we always are anxious to provide our readers with the stocks that the top firms feel have the most ...
Read Full Story »
biotech

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

On Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company ...
Read Full Story »
pills

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Although Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers expect to be ...
Read Full Story »
Bull and Bear figures

Closing Bell for Monday on Wall Street: Markets Open Higher, Hold Gains

July 1, 2013: U.S. equity markets opened higher this morning after a blast of economic data from both Asia and Europe. In China, June manufacturing PMI slid lower. Japan’s economics ...
Read Full Story »
Pills

Onyx Pharma Rejects Amgen, but Will Start Search for a Buyer

Cancer-drug developer Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) issued a terse press release yesterday, saying it had “received and rejected” a buyout offer from Amgen Inc. (NASDAQ: AMGN) for $120 per ...
Read Full Story »
biotech

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on ...
Read Full Story »
biotech

Top New Biotech Ideas From PropThink

The world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise is the ...
Read Full Story »
pills

Deutsche Bank Firm on Biotech Stocks to Buy

Biotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the ...
Read Full Story »